Promab Biotechnologies, located in Richmond, CA, is a leading provider of cutting-edge technologies in the field of biomedicine. With expertise in car t nk development, mrna lnp development, and antibody engineering, they offer innovative solutions to revolutionize cancer care and advance therapeutic applications.
Since 2001, Promab has generated over 5,000 monoclonal antibodies, filed 50 patents, completed 500 car t projects, and initiated 4 phase 2 clinical trials. Their services range from custom car t development to licensing car technology, fueling a new era in medicine with a focus on pushing the frontiers of healthcare.
Generated from the website